BIO-Europe

The partnership will leverage Combotope’s SMART-Phage platform to generate highly tumor-selective antibodies for next-generation cancer therapies.

CHOSA Oncology has established a business presence in Boston, Massachusetts, marking an important strategic step in the company's US commercialization for Platin-DRP.

Stratipath Breast has received CE marking under the In Vitro Diagnostic Regulation (IVDR, EU 2017/746), the EU's most stringent regulatory framework for in vitro diagnostic medical devices.

Elicera Therapeutics held a scientific advice meeting with the Swedish Medical Products Agency (MPA) regarding the planned first-in-human clinical study of ELC-401, the company’s iTANK-armed CAR T-cell candidate targeting IL13Ra2 in grade IV glioma.

After more than four years of full-scale war waged by Russia in Ukraine, Ukrainians’ physical and mental health – and the entire healthcare system – are under extreme pressure. Today, relief efforts focus on knowledge transfer, new ways of managing and operating healthcare, and long-term partnerships, while also drawing lessons from Ukraine’s own resilience, crisis responses, and rehabilitation solutions.

The company has entered into the agreement with Eli Lilly and Company regarding a potential new treatment combining BioArctic’s BrainTransporter technology with an undisclosed Lilly drug candidate in neurodegeneration.

After 18 hours of traveling from Gothenburg I’m heading to the main hospital in Cherkasy, Ukraine, which is a reasonably-sized hospital with about 800 beds. Apart from their everyday business they have had an extra 30,000 or so soldiers to take care of since the war started. They are worn out. The staff members are really trying to hang in there. They're running low on supplies but they’re not giving up.